Neogen (NEOG) Selling, General & Administrative (2010 - 2026)
Neogen (NEOG) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 349.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -207.22 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 60.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 60.30 Mn |
| Nov 30, 2025 | 65.21 Mn |
| Aug 31, 2025 | 60.89 Mn |
| May 31, 2025 | 52.97 Mn |
| Feb 28, 2025 | 55.80 Mn |
| Nov 30, 2024 | 57.77 Mn |
| Aug 31, 2024 | 51.67 Mn |
| May 31, 2024 | 50.96 Mn |
| Feb 29, 2024 | 52.09 Mn |
| Nov 30, 2023 | 51.72 Mn |
| Aug 31, 2023 | 45.12 Mn |
| May 31, 2023 | 49.81 Mn |
| Feb 28, 2023 | 46.42 Mn |
| Nov 30, 2022 | 77.00 Mn |
| Aug 31, 2022 | 27.94 Mn |
| May 31, 2022 | 21.76 Mn |
| Feb 28, 2022 | 25.00 Mn |
| Nov 30, 2021 | 22.61 Mn |
| Aug 31, 2021 | 13.38 Mn |
| May 31, 2021 | 12.85 Mn |